Blanket Purchase Agreement GS00F009DA-75F40126A00005

The Food and Drug Administration (FDA) established this Multiple Award Blanket Purchase Agreement (BPA) with Westat, Inc. to provide quick turnaround social science research services. Awarded on December 18, 2025, with an ultimate completion date of December 30, 2030, the contract carries a ceiling value of $70 million and does not utilize a small business set-aside. The BPA structure enables the FDA to issue task orders for expedited research and analytical support across social science domains, leveraging Westat's established capabilities in survey research, data collection, analysis, and program evaluation. As a parent contract under the General Services Administration Multiple Award Schedule, this vehicle allows flexible procurement of research services without requiring full and open competition for individual task orders.

Westat, Inc., a large established federal contractor headquartered in Rockville, Maryland, brings substantial expertise to this engagement through its 60+ years of experience providing comprehensive research and technical assistance to federal agencies. The contractor's relevant experience includes existing major research contracts with agencies such as the National Institutes of Health, Centers for Disease Control and Prevention, and the Agency for Healthcare Research and Quality, demonstrating proven capacity to execute complex, multi-faceted social science research initiatives. Under this BPA, Westat will deliver quick turnaround analytical and research services that support FDA's programmatic needs, including survey development and implementation, statistical analysis, data management, and evaluative research that inform regulatory and policy decisions. The multiple award structure allows the FDA to access Westat's services on an as-needed basis while maintaining flexibility in scope, timing, and delivery of individual research assignments throughout the five-year performance period.